Ilant Health began with a surprisingly ordinary failure: a patient had to find her own obesity care. Now it is trying to turn treatment matching, human support and financial accountability into one coherent benefit.
KEYTRUDA made Merck an oncology powerhouse. Now the 135-year-old drugmaker is spending, partnering and inventing its way toward a future that cannot depend on one medicine.